|
1
|
Chevalier X, Groult N, Emod I and
Planchenault T: Proteoglycan-degrading activity associated with the
40 kDa collagen-binding fragment of fibronectin. Br J Rheumatol.
35:506–514. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Berenbaum F and van den Berg WB:
Inflammation in osteoarthritis: Changing views. Osteoarthritis
Cartilage. 23:1823–1824. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Berenbaum F: Osteoarthritis as an
inflammatory disease (osteoarthritis is not osteoarthrosis!).
Osteoarthritis Cartilage. 21:16–21. 2013. View Article : Google Scholar
|
|
4
|
Fernandes JC, Martel-Pelletier J and
Pelletier JP: The role of cytokines in osteoarthritis
pathophysiology. Biorheology. 39:237–246. 2002.PubMed/NCBI
|
|
5
|
Goldring MB: The role of cytokines as
inflammatory mediators in osteoarthritis: Lessons from animal
models. Connect Tissue Res. 40:1–11. 1999. View Article : Google Scholar
|
|
6
|
Loeser RF: Molecular mechanisms of
cartilage destruction: Mechanics, inflammatory mediators, and aging
collide. Arthritis Rheum. 54:1357–1360. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wojdasiewicz P, Poniatowski LA and
Szukiewicz D: The role of inflammatory and anti-inflammatory
cytokines in the pathogenesis of osteoarthritis. Mediators Inflamm.
2014:5614592014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shakibaei M, Schulze-Tanzil G, John T and
Mobasheri A: Curcumin protects human chondrocytes from
IL-l1beta-induced inhibition of collagen type II and beta1-integrin
expression and activation of caspase-3: An immunomorphological
study. Ann Anat. 187:487–497. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Stove J, Huch K, Gunther KP and Scharf HP:
Interleukin-1beta induces different gene expression of stromelysin,
aggrecan and tumor-necrosis-factor-stimulated gene 6 in human
osteoarthritic chondrocytes in vitro. Pathobiology. 68:144–149.
2000. View Article : Google Scholar
|
|
10
|
Mengshol JA, Vincenti MP, Coon CI,
Barchowsky A and Brinckerhoff CE: Interleukin-1 induction of
collagenase 3 (matrix metalloproteinase 13) gene expression in
chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear
factor kappaB: Differential regulation of collagenase 1 and
collagenase 3. Arthritis Rheum. 43:801–811. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Matsushita T, Sasaki H, Takayama K, Ishida
K, Matsumoto T, Kubo S, Matsuzaki T, Nishida K, Kurosaka M and
Kuroda R: The overexpression of SIRT1 inhibited osteoarthritic gene
expression changes induced by interleukin-1β in human chondrocytes.
J Orthop Res. 31:531–537. 2013. View Article : Google Scholar
|
|
12
|
Wang M, Sampson ER, Jin H, Li J, Ke QH, Im
HJ and Chen D: MMP13 is a critical target gene during the
progression of osteoarthritis. Arthritis Res Ther. 15:R52013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Miller RE, Tran PB, Ishihara S, Larkin J
and Malfait AM: Therapeutic effects of an anti-ADAMTS-5 antibody on
joint damage and mechanical allodynia in a murine model of
osteoarthritis. Osteoarthritis Cartilage. 24:299–306. 2016.
View Article : Google Scholar :
|
|
14
|
Ishibashi K, Hara S and Kondo S: Aquaporin
water channels in mammals. Clin Exp Nephrol. 13:107–117. 2009.
View Article : Google Scholar
|
|
15
|
Tsukaguchi H, Weremowicz S, Morton CC and
Hediger MA: Functional and molecular characterization of the human
neutral solute channel aquaporin-9. Am J Physiol. 277:F685–F696.
1999.PubMed/NCBI
|
|
16
|
Ishibashi K: New members of mammalian
aquaporins: AQP10-AQP12. Handb Exp Pharmacol. 251–262. 2009.
View Article : Google Scholar
|
|
17
|
Verkman AS: Roles of aquaporins in kidney
revealed by transgenic mice. Semin Nephrol. 26:200–208. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sohara E, Rai T, Sasaki S and Uchida S:
Physiological roles of AQP7 in the kidney: Lessons from AQP7
knockout mice. Biochim Biophys Acta. 1758:1106–1110. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ko SB, Mizuno N, Yatabe Y, Yoshikawa T,
Ishiguro H, Yamamoto A, Azuma S, Naruse S, Yamao K, Muallem S and
Goto H: Aquaporin 1 water channel is overexpressed in the plasma
membranes of pancreatic ducts in patients with autoimmune
pancreatitis. J Med Invest. 56(Suppl): 318–321. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Huysseune S, Kienlen-Campard P, Hebert S,
Tasiaux B, Leroy K, Devuyst O, Brion JP, De Strooper B and Octave
JN: Epigenetic control of aquaporin 1 expression by the amyloid
precursor protein. FASEB J. 23:4158–4167. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mobasheri A, Moskaluk CA, Marples D and
Shakibaei M: Expression of aquaporin 1 (AQP1) in human synovitis.
Ann Anat. 192:116–121. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rojek AM, Skowronski MT, Fuchtbauer EM,
Füchtbauer AC, Fenton RA, Agre P, Frøkiaer J and Nielsen S:
Defective glycerol metabolism in aquaporin 9 (AQP9) knockout mice.
Proc Natl Acad Sci USA. 104:3609–3614. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Spegel P, Chawade A, Nielsen S, Kjellbom P
and Rutzler M: Deletion of glycerol channel aquaporin-9 (Aqp9)
impairs long-term blood glucose control in C57BL/6 leptin
receptor-deficient (db/db) obese mice. Physiol Rep. 3:e125382015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Naka M, Kanamori A, Negi A and Nakamura M:
Reduced expression of aquaporin-9 in rat optic nerve head and
retina following elevated intraocular pressure. Invest Ophthalmol
Vis Sci. 51:4618–4626. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
de Baey A and Lanzavecchia A: The role of
aquaporins in dendritic cell macropinocytosis. J Exp Med.
191:743–748. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhu N, Feng X, He C, Gao H, Yang L, Ma Q,
Guo L, Qiao Y, Yang H and Ma T: Defective macrophage function in
aquaporin-3 deficiency. FASEB J. 25:4233–4239. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Rabolli V, Wallemme L, Lo Re S,
Uwambayinema F, Palmai-Pallag M, Thomassen L, Tyteca D, Octave JN,
Marbaix E, Lison D, et al: Critical role of aquaporins in
interleukin 1β(IL-1β)-induced inflammation. J Biol Chem.
289:13937–13947. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nagahara M, Waguri-Nagaya Y, Yamagami T,
Aoyama M, Tada T, Inoue K, Asai K and Otsuka T: TNF-alpha-induced
aquaporin 9 in synoviocytes from patients with OA and RA.
Rheumatology (Oxford). 49:898–906. 2010. View Article : Google Scholar
|
|
29
|
General Assembly of the World Medical
Association: World medical association declaration of helsinki:
Ethical principles for medical research involving human subjects. J
Am Coll Dent. 81:14–18. 2014.
|
|
30
|
Mankin HJ, Dorfman H, Lippiello L and
Zarins A: Biochemical and metabolic abnormalities in articular
cartilage from osteo-arthritic human hips. II Correlation of
morphology with biochemical and metabolic data. J Bone Joint Surg
Am. 53:523–537. 1971. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pattoli MA, MacMaster JF, Gregor KR and
Burke JR: Collagen and aggrecan degradation is blocked in
interleukin-1-treated cartilage explants by an inhibitor of IkappaB
kinase through suppression of metalloproteinase expression. J
Pharmacol Exp Ther. 315:382–388. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kihara S, Hayashi S, Hashimoto S, Kanzaki
N, Takayama K, Matsumoto T, Chinzei N, Iwasa K, Haneda M, Takeuchi
K, et al: Cyclin-dependent kinase inhibitor-1-deficient mice are
susceptible to osteoarthritis associated with enhanced
inflammation. J Bone Miner Res. 32:991–1001. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
34
|
Matsushima A, Ogura H, Koh T, Shimazu T
and Sugimoto H: Enhanced expression of aquaporin 9 in activated
polymor-phonuclear leukocytes in patients with systemic
inflammatory response syndrome. Shock. 42:322–326. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mesko B, Poliska S, Szegedi A, Szekanecz
Z, Palatka K, Papp M and Nagy L: Peripheral blood gene expression
patterns discriminate among chronic inflammatory diseases and
healthy controls and identify novel targets. BMC Med Genomics.
3:152010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gilmore TD: The Rel/NF-kappaB signal
transduction pathway: Introduction. Oncogene. 18:6842–6844. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Holgate ST: Cytokine and anti-cytokine
therapy for the treatment of asthma and allergic disease. Cytokine.
28:152–157. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Williams RO, Paleolog E and Feldmann M:
Cytokine inhibitors in rheumatoid arthritis and other autoimmune
diseases. Curr Opin Pharmacol. 7:412–417. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Liu SF and Malik AB: NF-kappa B activation
as a pathological mechanism of septic shock and inflammation. Am J
Physiol Lung Cell Mol Physiol. 290:L622–L645. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wang BF, Cui ZW, Zhong ZH, Sun YH, Sun QF,
Yang GY and Bian LG: Curcumin attenuates brain edema in mice with
intracerebral hemorrhage through inhibition of AQP4 and AQP9
expression. Acta Pharmacol Sin. 36:939–948. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yang M, Gao F, Liu H, Yu WH and Sun SQ:
Temporal changes in expression of aquaporin-3, -4, -5 and -8 in rat
brains after permanent focal cerebral ischemia. Brain Res.
1290:121–132. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Song TT, Bi YH, Gao YQ, Huang R, Hao K, Xu
G, Tang JW, Ma ZQ, Kong FP, Coote JH, et al: Systemic
pro-inflammatory response facilitates the development of cerebral
edema during short hypoxia. J Neuroinflammation. 13:632016.
View Article : Google Scholar : PubMed/NCBI
|
